← Leaderboards
Andrew Spence
Temple Univ Of The Commonwealth
$1,969,032
Attributed
$1,969,032
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $416.3K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,969,032 · 1
By mechanism
R01$1,969,032 · 1
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Linda Jasmine Hoffman$39,385
Others in their field
Other Emerging Leaders on “Human Model”
- Leonard Freedman · Leidos Biomedical Research, Inc.$92,774,973
- Ted Ross · University Of Georgia$70,992,558
- Martha Hering · Westat, Inc.$57,098,843
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Sarah Fortune · Harvard School Of Public Health$51,119,645
Research focus
Human ModelAffectHistologicH-ReflexAnimal ModelBehavioralAfferent NeuronsComplexGrantCutaneousData SetDeep LearningDensityDesigner Receptors Exclusively Activated By Designer DrugsAnimalsDissectionEffective TherapyElectric StimulationCoupledAxonFeedingFunctional PlasticityGeneticImpairment
Grant awards (5)
Chemogenetic afferent modulation to understand spinal cord circuit function and plasticity post injury$374,900
R01 · FY2024 · NS · contact PI
Chemogenetic afferent modulation to understand spinal cord circuit function and plasticity post injury$390,183
R01 · FY2023 · NS · contact PI
Chemogenetic afferent modulation to understand spinal cord circuit function and plasticity post injury$391,984
R01 · FY2022 · NS · contact PI
Chemogenetic afferent modulation to understand spinal cord circuit function and plasticity post injury$395,672
R01 · FY2021 · NS · contact PI
Chemogenetic afferent modulation to understand spinal cord circuit function and plasticity post injury$416,293
R01 · FY2020 · NS · contact PI